Your body’s immune system is designed to recognise and destroy abnormal cells.

Cancer cells can sometimes avoid being detected by the immune system.

This means the body may not recognise the cancer cells as something that needs to be attacked.

Researchers are investigating new ways to help the immune system recognise and fight cancer more effectively.

One approach is a personalised cancer vaccine.

This type of vaccine is created using information from an individual patient’s tumour.

Scientists analyse the tumour and identify specific markers that are unique to that cancer.

These markers are then used to design a vaccine tailored to that individual patient.

The aim is to train the immune system to recognise and attack cells that carry these markers.

The BNT122-01 study is investigating this personalised vaccine approach.

The study is looking at whether the vaccine can help reduce the risk of cancer returning after treatment.

If you decide to take part in the study, your doctor will explain what participation involves.

Taking part is voluntary and you can leave the study at any time.

The results of this research may help develop new ways of treating cancer in the future.